Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors

Citation

Sheppard, K, Cullinane, C, Hannan, K et al 2013, 'Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors', European Journal of Cancer, vol. 49, no. 18, pp. 3936-3944.

Year

2013

ANU Authors

Fields of Research

  • Receptors And Membrane Biology
  • Cancer Cell Biology
  • Molecular Targets

Updated:  01 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers